Royal Bank Of Canada Amgen Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Amgen Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 4,799,264 shares of AMGN stock, worth $1.38 Billion. This represents 0.33% of its overall portfolio holdings.

Number of Shares

4,799,264

Previous 5,022,664 4.45%

Holding current value

$1.38 Billion

Previous $1.57 Billion 1.46%

% of portfolio

0.33%

Previous 0.37%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $69.1 Million - $75.4 Million	-223,400 Reduced 4.45%	4,799,264 $1.55 Billion
Q2 2024 Nov 06, 2024	SELL	$262.75 - $319.31 $17 Million - $20.7 Million	-64,700 Reduced 1.27%	5,022,664 $1.57 Billion
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $98 Million - $119 Million	-372,823 Reduced 6.83%	5,087,364 $1.59 Billion
Q1 2024 Nov 05, 2024	BUY	$268.87 - $324.56 $82.7 Million - $99.8 Million	307,474 Added 6.04%	5,394,838 $1.53 Billion
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $99.9 Million - $121 Million	-371,437 Reduced 6.37%	5,460,187 $1.55 Billion
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $192 Million - $217 Million	751,947 Added 14.8%	5,831,624 $1.68 Billion
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $113 Million - $141 Million	518,689 Added 11.37%	5,079,677 $1.37 Billion
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $70.1 Million - $82.9 Million	327,323 Added 7.73%	4,560,988 $1.01 Billion
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $421 Million - $514 Million	-1,866,161 Reduced 30.59%	4,233,665 $1.02 Billion
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $490,811 - $623,634	2,143 Added 0.04%	6,099,826 $1.6 Billion
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $17 Million - $19.2 Million	75,721 Added 1.26%	6,097,683 $1.37 Billion
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $379 Million - $421 Million	1,641,374 Added 37.47%	6,021,962 $1.47 Billion
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $25.8 Million - $28.5 Million	117,644 Added 2.76%	4,380,588 $1.06 Billion
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $67.8 Million - $77.6 Million	340,736 Added 8.69%	4,262,944 $959 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $43.8 Million - $51.3 Million	-206,162 Reduced 4.99%	3,922,208 $834 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $964 Million - $1.07 Billion	4,128,370 New	4,128,370 $1.01 Billion

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Amgen Inc Transaction History